Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

A rare autism-associated MINT2/APBA2 mutation disrupts neurexin trafficking and synaptic function.

Lin AY, Henry S, Reissner C, Neupert C, Kenny C, Missler M, Beffert U, Ho A.

Sci Rep. 2019 Apr 15;9(1):6024. doi: 10.1038/s41598-019-42635-7.

2.

CLASP2 Links Reelin to the Cytoskeleton during Neocortical Development.

Dillon GM, Tyler WA, Omuro KC, Kambouris J, Tyminski C, Henry S, Haydar TF, Beffert U, Ho A.

Neuron. 2017 Mar 22;93(6):1344-1358.e5. doi: 10.1016/j.neuron.2017.02.039. Epub 2017 Mar 9.

3.

Differential splicing and glycosylation of Apoer2 alters synaptic plasticity and fear learning.

Wasser CR, Masiulis I, Durakoglugil MS, Lane-Donovan C, Xian X, Beffert U, Agarwala A, Hammer RE, Herz J.

Sci Signal. 2014 Nov 25;7(353):ra113. doi: 10.1126/scisignal.2005438.

4.

Microtubule plus-end tracking protein CLASP2 regulates neuronal polarity and synaptic function.

Beffert U, Dillon GM, Sullivan JM, Stuart CE, Gilbert JP, Kambouris JA, Ho A.

J Neurosci. 2012 Oct 3;32(40):13906-16. doi: 10.1523/JNEUROSCI.2108-12.2012.

5.

The Reelin receptors Apoer2 and Vldlr coordinate the patterning of Purkinje cell topography in the developing mouse cerebellum.

Larouche M, Beffert U, Herz J, Hawkes R.

PLoS One. 2008 Feb 27;3(2):e1653. doi: 10.1371/journal.pone.0001653.

6.

Contribution of the Reelin signaling pathways to nociceptive processing.

Akopians AL, Babayan AH, Beffert U, Herz J, Basbaum AI, Phelps PE.

Eur J Neurosci. 2008 Feb;27(3):523-37. doi: 10.1111/j.1460-9568.2008.06056.x.

PMID:
18279306
7.

The Pafah1b complex interacts with the reelin receptor VLDLR.

Zhang G, Assadi AH, McNeil RS, Beffert U, Wynshaw-Boris A, Herz J, Clark GD, D'Arcangelo G.

PLoS One. 2007 Feb 28;2(2):e252.

8.

ApoE receptor 2 controls neuronal survival in the adult brain.

Beffert U, Nematollah Farsian F, Masiulis I, Hammer RE, Yoon SO, Giehl KM, Herz J.

Curr Biol. 2006 Dec 19;16(24):2446-52.

9.

Increased risk for heterozygotes in recessive Parkinson disease.

Beffert U, Rosenberg RN.

Arch Neurol. 2006 Jun;63(6):807-8. No abstract available.

PMID:
16769859
10.
11.

F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein.

Hoe HS, Wessner D, Beffert U, Becker AG, Matsuoka Y, Rebeck GW.

Mol Cell Biol. 2005 Nov;25(21):9259-68.

12.

Reelin modulates NMDA receptor activity in cortical neurons.

Chen Y, Beffert U, Ertunc M, Tang TS, Kavalali ET, Bezprozvanny I, Herz J.

J Neurosci. 2005 Sep 7;25(36):8209-16.

13.

Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2.

Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher M, Hammer RE, Herz J.

Neuron. 2005 Aug 18;47(4):567-79.

14.

The apoE receptor apoER2 is involved in the maintenance of efficient synaptic plasticity.

Petit-Turcotte C, Aumont N, Beffert U, Dea D, Herz J, Poirier J.

Neurobiol Aging. 2005 Feb;26(2):195-206.

PMID:
15582748
15.

Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice.

May P, Rohlmann A, Bock HH, Zurhove K, Marth JD, Schomburg ED, Noebels JL, Beffert U, Sweatt JD, Weeber EJ, Herz J.

Mol Cell Biol. 2004 Oct;24(20):8872-83.

16.

A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons.

Morfini G, Szebenyi G, Brown H, Pant HC, Pigino G, DeBoer S, Beffert U, Brady ST.

EMBO J. 2004 Jun 2;23(11):2235-45. Epub 2004 May 20.

17.

Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission.

Beffert U, Weeber EJ, Morfini G, Ko J, Brady ST, Tsai LH, Sweatt JD, Herz J.

J Neurosci. 2004 Feb 25;24(8):1897-906.

18.

Functions of lipoprotein receptors in neurons.

Beffert U, Stolt PC, Herz J.

J Lipid Res. 2004 Mar;45(3):403-9. Epub 2003 Dec 1. Review.

19.

Interaction of reelin signaling and Lis1 in brain development.

Assadi AH, Zhang G, Beffert U, McNeil RS, Renfro AL, Niu S, Quattrocchi CC, Antalffy BA, Sheldon M, Armstrong DD, Wynshaw-Boris A, Herz J, D'Arcangelo G, Clark GD.

Nat Genet. 2003 Nov;35(3):270-6. Epub 2003 Oct 26.

PMID:
14578885
20.

Fast axonal transport misregulation and Alzheimer's disease.

Morfini G, Pigino G, Beffert U, Busciglio J, Brady ST.

Neuromolecular Med. 2002;2(2):89-99. Review.

PMID:
12428805
21.

Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta.

Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, Herz J.

J Biol Chem. 2002 Dec 20;277(51):49958-64. Epub 2002 Oct 9.

22.

Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning.

Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J.

J Biol Chem. 2002 Oct 18;277(42):39944-52. Epub 2002 Aug 7.

23.

Apolipoprotein C-I expression in the brain in Alzheimer's disease.

Petit-Turcotte C, Stohl SM, Beffert U, Cohn JS, Aumont N, Tremblay M, Dea D, Yang L, Poirier J, Shachter NS.

Neurobiol Dis. 2001 Dec;8(6):953-63.

PMID:
11741391
24.

Apolipoprotein E receptors: linking brain development and Alzheimer's disease.

Herz J, Beffert U.

Nat Rev Neurosci. 2000 Oct;1(1):51-8. Review.

PMID:
11252768
25.

Brain lipoprotein metabolism and its relation to neurodegenerative disease.

Danik M, Champagne D, Petit-Turcotte C, Beffert U, Poirier J.

Crit Rev Neurobiol. 1999;13(4):357-407. Review.

PMID:
11028681
26.

Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.

Ramassamy C, Averill D, Beffert U, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Schoofs A, Davignon J, Poirier J.

Neurobiol Dis. 2000 Feb;7(1):23-37.

PMID:
10671320
27.

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.

Beffert U, Cohn JS, Petit-Turcotte C, Tremblay M, Aumont N, Ramassamy C, Davignon J, Poirier J.

Brain Res. 1999 Oct 2;843(1-2):87-94.

PMID:
10528114
28.

Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.

Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Davignon J, Quirion R, Poirier J.

Free Radic Biol Med. 1999 Sep;27(5-6):544-53.

PMID:
10490274
29.

Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures.

Beffert U, Aumont N, Dea D, Lussier-Cacan S, Davignon J, Poirier J.

Brain Res Mol Brain Res. 1999 May 7;68(1-2):181-5.

PMID:
10320795
30.
31.

ApoE associated with lipid has a reduced capacity to inhibit beta-amyloid fibril formation.

Beffert U, Poirier J.

Neuroreport. 1998 Oct 5;9(14):3321-3.

PMID:
9831470
32.

HSV-1 in brain and risk of Alzheimer's disease.

Beffert U, Bertrand P, Champagne D, Gauthier S, Poirier J.

Lancet. 1998 May 2;351(9112):1330-1. No abstract available.

PMID:
9643802
33.

The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.

Beffert U, Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J.

Brain Res Brain Res Rev. 1998 Jul;27(2):119-42. Review.

PMID:
9622609
34.

Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons.

Beffert U, Aumont N, Dea D, Lussier-Cacan S, Davignon J, Poirier J.

J Neurochem. 1998 Apr;70(4):1458-66.

35.

Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.

Beffert U, Poirier J.

Ann N Y Acad Sci. 1996 Jan 17;777:166-74.

PMID:
8624080
36.

Increased levels of statin, a marker of cell cycle arrest, in response to hippocampal neuronal injury.

Poirier J, Beffert U, Dea D, Alonso R, O'Donnell D, Boksa P.

Brain Res Mol Brain Res. 1995 Dec 1;34(1):57-64.

PMID:
8750861

Supplemental Content

Loading ...
Support Center